Form 8-K - Current report:
SEC Accession No. 0000200406-25-000106
Filing Date
2025-04-03
Accepted
2025-04-03 16:43:02
Documents
17
Period of Report
2025-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20250331.htm   iXBRL 8-K 40045
2 EX-99 pressrelease-redriverdenia.htm EX-99 13470
7 image_0a.jpg GRAPHIC 244
8 image_1a.jpg GRAPHIC 19328
  Complete submission text file 0000200406-25-000106.txt   312379

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20250331.xsd EX-101.SCH 4583
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20250331_def.xml EX-101.DEF 10568
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20250331_lab.xml EX-101.LAB 38371
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20250331_pre.xml EX-101.PRE 22234
19 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20250331_htm.xml XML 10686
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 25810272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)